(NASDAQ:THAR) ("Tharimmune"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, and Intract Pharma Ltd. ("Intract"), a ...
Dr. Shirazian agrees that you should full send for the 7-day Monistat to fix a yeast infection, "even if you're not someone who has recurrent or prolonged yeast infections". "The treatment goes ...
AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...